X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (128) 128
index medicus (88) 88
pathology (74) 74
male (68) 68
female (63) 63
immunohistochemistry (57) 57
middle aged (56) 56
aged (52) 52
cancer (46) 46
oncology (43) 43
adult (39) 39
tumors (39) 39
article (32) 32
animals (28) 28
carcinoma (28) 28
expression (25) 25
aged, 80 and over (22) 22
kidney neoplasms - pathology (22) 22
metastasis (21) 21
adenocarcinoma (20) 20
biomarkers, tumor - metabolism (20) 20
microbiology (20) 20
biomarkers, tumor - analysis (19) 19
biochemistry (18) 18
gene expression regulation, neoplastic (18) 18
surgery (18) 18
beer (17) 17
chemistry (17) 17
compositions thereof (17) 17
culture media (17) 17
enzymology (17) 17
gene expression (17) 17
gene-expression (17) 17
metallurgy (17) 17
microorganisms or enzymes (17) 17
mutation or genetic engineering (17) 17
propagating, preserving or maintaining microorganisms (17) 17
spirits (17) 17
vinegar (17) 17
wine (17) 17
mice (16) 16
mutation (16) 16
research (16) 16
analysis (15) 15
renal cell carcinoma (15) 15
adenocarcinoma - pathology (14) 14
diagnosis (14) 14
gene expression profiling (14) 14
human necessities (14) 14
hygiene (14) 14
kidney neoplasms - genetics (14) 14
lung cancer (14) 14
medical or veterinary science (14) 14
oligonucleotide array sequence analysis (14) 14
organic chemistry (14) 14
peptides (14) 14
preparations for medical, dental, or toilet purposes (14) 14
cell line, tumor (13) 13
prostatic neoplasms - pathology (13) 13
biopsy (12) 12
carcinoma, renal cell - pathology (12) 12
kidney neoplasms - metabolism (12) 12
mutations (12) 12
prostate cancer (12) 12
adenocarcinoma - metabolism (11) 11
breast-cancer (11) 11
c-met (11) 11
cell biology (11) 11
diagnosis, differential (11) 11
phosphorylation (11) 11
prognosis (11) 11
signal transduction (11) 11
urinary bladder neoplasms - pathology (11) 11
carcinoma, renal cell (10) 10
carcinoma, renal cell - genetics (10) 10
carcinoma, renal cell - metabolism (10) 10
immunoenzyme techniques (10) 10
tissue array analysis (10) 10
abridged index medicus (9) 9
cells (9) 9
disease progression (9) 9
genetic aspects (9) 9
lung neoplasms - genetics (9) 9
lung neoplasms - metabolism (9) 9
lung neoplasms - pathology (9) 9
medicine, research & experimental (9) 9
neoplasm staging (9) 9
patients (9) 9
prostate (9) 9
reproducibility of results (9) 9
reverse transcriptase polymerase chain reaction (9) 9
treatment outcome (9) 9
apoptosis (8) 8
cell differentiation (8) 8
cell proliferation (8) 8
colorectal-cancer (8) 8
features (8) 8
growth (8) 8
neoplasms (8) 8
oncocytoma (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Pathology, ISSN 0046-8177, 10/2018, Volume 80, pp. 65 - 75
Journal Article
Journal Article
Cancer Genetics, ISSN 2210-7762, 04/2019, Volume 233-234, pp. S6 - S6
Journal Article
Case Reports in Pathology, ISSN 2090-6781, 10/2019, Volume 2019, pp. 1 - 4
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy arising from precursors of plasmacytoid dendritic cells... 
Journal Article
Molecular Systems Biology, ISSN 1744-4292, 2008, Volume 4, Issue 1, pp. 188 - n/a
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 10/2014, Volume 142, Issue suppl_1, pp. A207 - A207
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2169 - 2176
Purpose: Prostate cancer is dependent on androgen receptor (AR) activation. Optimal AR antagonism may effectively cytoreduce local disease and suppress or... 
THERAPY | ANTIANDROGEN | ONCOLOGY | RESISTANCE | PHASE-II | RADICAL PROSTATECTOMY | INCREASED SURVIVAL | CANCER | CHEMOTHERAPY | PROGRESSION | ABIRATERONE | Neoplasm, Residual - pathology | Phenylthiohydantoin - adverse effects | Prostatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Combined Modality Therapy | Neoplasm, Residual - blood | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Phenylthiohydantoin - administration & dosage | Receptors, Androgen - genetics | Leuprolide - administration & dosage | Neoadjuvant Therapy - adverse effects | Prostatic Neoplasms - blood | Prostatectomy | Aged | Neoplasm, Residual - chemically induced | Dutasteride - administration & dosage | Prostatic Neoplasms - drug therapy | Therapy | Risk groups | Health risks | Minimal residual disease | Patients | Anticancer properties | Testosterone | Signaling | Dihydrotestosterone | Androgens | Flutamide | Experimental design | Luteinizing hormone | Luteinizing hormone-releasing hormone | Antitumor activity | Prostate cancer | Prostate | Cancer | dutasteride | neoadjuvant | NEW MOLECULAR TARGETS | THERAPEUTICS: Cellular responses to anticancer drugs | CL01 PHASE I – III CLINICAL TRIALS: Phase I–III Trials_Genitourinary cancers: prostate | ET02 MECHANISMS OF DRUG ACTION | enzalutamide
Journal Article
Modern Pathology, ISSN 0893-3952, 02/2006, Volume 19, Issue 2, pp. 264 - 271
Journal Article
Virchows Archiv, ISSN 0945-6317, 7/2018, Volume 473, Issue 1, pp. 85 - 93
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 04/2009, Volume 69, Issue 7, pp. 3077 - 3085
Journal Article
Cancer Cell, ISSN 1535-6108, 06/2015, Volume 27, Issue 6, pp. 797 - 808
Journal Article
International Journal of Surgical Pathology, ISSN 1066-8969, 12/2018, Volume 26, Issue 8, pp. 721 - 724
Extranodal lymphomas involve adrenal glands as a mass lesion in 3% to 5% of cases as identified by imaging studies. Definitive diagnosis of the neoplasm is... 
renal cell carcinoma | neoplasm | adrenal | PAX8 | lymphoma | SURGERY | PATHOLOGY | TUMORS
Journal Article